5//SEC Filing
NIELSEN TYLER MARSHALL 5
Accession 0000914190-11-000097
CIK 0001140028other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:20 PM ET
Size
7.2 KB
Accession
0000914190-11-000097
Insider Transaction Report
Form 5
NIELSEN TYLER MARSHALL
Controller
Transactions
- Award
Stock Option (right to buy)
2010-11-01+5,000→ 15,000 totalExercise: $0.76Exp: 2020-02-16→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]On 9/10/10, the Company completed a one-for-four reverse stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to 9/10/10 have been adjusted to reflect the one-for-four reverse stock split.
- [F2]On 2/16/10, the Reporting Person was granted an option (the "Standard Option") to purchase up to 10,000 shares of common stock, vesting as to one-third of the underlying shares on 2/16/11, with the remaining two-thirds vesting in 24 equal monthly installments thereafter. Also on 2/16/10, the Reporting Person was granted an option (the "Performance Option") to purchase up to 10,000 shares of common stock with the same vesting schedule as the Standard Option, provided that the vesting of the Performance Option was also conditioned upon the achievement of two specified regulatory milestones. On 11/1/10, it was determined that only one of the two milestones had been satisfied. As a result, the right to purchase 5,000 shares subject to the Performance Option is no longer conditioned upon the achievement of any milestone, and the right to purchase 5,000 shares subject to the Performance Option lapsed.
Documents
Issuer
Talon Therapeutics, Inc.
CIK 0001140028
Entity typeother
Related Parties
1- filerCIK 0001357320
Filing Metadata
- Form type
- 5
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 4:20 PM ET
- Size
- 7.2 KB